Bone morphogenetic protein 6 and oxidized low-density lipoprotein synergistically recruit osteogenic differentiation

Lai-Ming Yung1, Gonzalo Sánchez-Duffhues2, Peter Ten Dijke2

  • 1Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA.

Cardiovascular Research
|September 28, 2015
PubMed

Insights

Bone morphogenetic protein 6 (BMP6) and oxidized low-density lipoprotein (oxLDL) promote vascular calcification by inducing osteogenic differentiation in endothelial cells (ECs). This process involves oxidative stress and BMP signaling, contributing to atherosclerosis.

Area of Science:

  • Vascular Biology
  • Cellular Differentiation
  • Biochemistry

Background:

  • Vascular calcification is a significant contributor to mortality in atherosclerosis, chronic kidney disease, and diabetes.
  • Vascular lesions contain cells resembling osteoblasts and chondroblasts, suggesting ossification processes driven by vascular cell plasticity.
  • Bone morphogenetic protein (BMP) signaling exacerbates atherosclerotic calcification, while its inhibition reduces vascular inflammation and calcification in mice.

Purpose of the Study:

  • To investigate the hypothesis that endothelial cells (ECs) undergo osteogenic differentiation in response to BMP signaling and pro-atherogenic stimuli.
  • To elucidate the mechanisms by which BMPs and oxidized low-density lipoprotein (oxLDL) induce vascular calcification.

Main Methods:

  • Bovine aortic endothelial cells (BAECs) and human aortic endothelial cells were treated with various BMP ligands, oxLDL, and hydrogen peroxide (H2O2).
  • Gene expression analysis focused on osteogenic and chondrogenic transcription factors (Runx2, Msx2, Osterix, Osteopontin).
  • Mineralization assays were performed, with interventions including reactive oxygen species scavengers and BMP type I receptor kinase inhibitors.

Main Results:

  • BMP6 and BMP9 showed potent signaling in BAECs, with BMP6 inducing osteogenic differentiation.
  • BMP6 and oxLDL synergistically induced osteogenic differentiation and mineralization in ECs, consistent with endothelial-to-mesenchymal transition.
  • H2O2 was essential for oxLDL-induced gene regulation, and BMP6/oxLDL treatments upregulated specific osteogenic markers, effects blocked by ROS scavenging or kinase inhibition.

Conclusions:

  • Findings suggest a mechanism linking BMP signaling, oxidative stress, and inflammation in vascular calcification associated with atherosclerosis.
  • Endothelial cells can differentiate into osteogenic phenotypes under specific stimuli, contributing to vascular calcification.
  • BMP6 and oxLDL act synergistically to promote EC osteogenic differentiation and mineralization, highlighting potential therapeutic targets.
Abstract